Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - TOTAL EQUITY
Total Equity EBS - Emergent BioSolutions Inc.
649 M
LAST VALUE
-36.67%
2 YEAR CAGR
-8.47%
5 YEAR CAGR
2.87%
10 YEAR CAGR